Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Maxim notified of patent allowance for MaxVax technology

March 20, 1997

Pharmacokinetic model described for BMS-188667

March 18, 1997

First live oral cholera vaccine approved in Canada

March 13, 1997

Activated immunoglobulins reported by Nippon Zoki

March 12, 1997

Positive preliminary results for rotavirus vaccine

March 7, 1997

SangStat receives European patent for Xenoject drugs

March 5, 1997

WF-10 undergoes further clinical studies for AIDS

March 5, 1997

Novel class of immunosuppressants disclosed by Novartis

March 4, 1997

Optivax phase I results reported at AAAI/AAI/CIS meeting

Feb. 27, 1997

Immunoregulatory protein discovered by Boehringer Mannheim

Feb. 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 19, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...